Cataract Kush (S-LAB, Synoptis Pharma, Tilray): lineage from LA Confidential and myrcene

What is Cataract Kush and where does this strain come from?

Cataract Kush is an indica strain developed by DNA Genetics from the cross of LA Confidential and OG Kush. The lineage is recorded in the SeedFinder database and is not based on assumptions from the name. It reaches Polish pharmacies as dried flower in four registered positions, and its terpene profile is led by myrcene.

The lineage record is a declaration from the breeder, not a result of genetic testing performed on the material sold in pharmacies. This distinction is important when reading the entire summary: the origin indicates what the strain was derived from and does not determine how a specific batch of dried flower approved for sale in Poland will behave.

The second parent shows the boundary of this documentation. OG Kush is listed in the pedigree graph of this cluster as a broad family of style, not as a single identified plant, and it also reaches Polish pharmacies as a separate entry without established origin. Thus, the descendant has documented parents, but one of those parents is not documented.

The name is not a hint here. The same component is shared in this cluster by ten cultivars, half of which have established origins, while the other half do not have any. Blood Orange Kush derives from a completely different pair of parents than the strain described here, although both names sound similar. The shared word does not prove kinship in any direction.

Which producers supply Cataract Kush to Polish pharmacies?

Three. Cataract Kush leads S-LAB, Synoptis Pharma and Tilray, together in four registered positions, because Tilray has two versions differing in declared strength, while the other producers have one each. All four positions are described with the same set of terpenes, attributed to the strain name, although they come from three different facilities.

The total declared THC content range is 16.2-24.2%. This range does not come from measurements taken in pharmacies or from the margins of a single producer. Cataract Kush is listed in the positions of three different companies, each declaring its own nominal value and adding an allowable deviation of one-tenth up and down. Only these separate ranges, overlapping, make up one range. Providing a single number would promise precision that the approving document does not guarantee.

An identical set of terpenes across all four products does not mean that the dried flower from three different facilities smells the same. It means that the description comes from a single entry assigned to the strain name, not from separate batch analyses. Availability changes faster than this description, as it depends on the import cycle and the permits, which have their own expiration dates. In the registration designation of the strain name, there is actually no information: it contains the manufacturer and the declared content, so it is not the trade name that defines the identity of the product in circulation. The current state notes a summary of available strains, updated separately from this text.

How does Cataract Kush smell and taste?

Heavy and earthy, with a peppery finish. The only available source assigns the same set of sensations to all four medicinal products: woody, earthy, sweet, fruity, spicy, and herbal. However, the aroma of the dried flower depends on the batch, the drying method, and the storage conditions, so the strain description is a starting point, not a guarantee.

The set of terpenes explains part of these associations. Myrcene leans towards earthy and hoppy notes, caryophyllene wnosi pieprz, limonene cytrus, pinene resin, linalool ton kwiatowy, a humulene returns to hops.

What is missing from this description is the proportions. The shares of individual components are sometimes provided in strain databases, but their sums for the same products give 46 percent in one comparison, 73 in another, and 83 in a third, so the denominator is different each time. A number without a known denominator looks like a measurement, although it is not, which is why only the composition stands here.

When vaporizing, the taste impression changes during the session. The first puffs carry lighter, more citrusy and resinous notes, and the higher the setting and the longer the session lasts, the more the earthy and peppery tones come out, up to the impression of burning at the upper limit of the range, when mainly the heaviest components of the profile are leaving the chamber.

How long does it take for Cataract Kush to take effect and how long does the effect last?

Inhaled within a few minutes, orally much later. After vaporization, the concentration of THC in the blood peaks between the third and tenth minute, and the perceived effect diminishes after two to four hours at most. The oral route delays the onset by up to half an hour, and sometimes up to an hour and a half.

These numbers describe THC administered inhaled or orally, not this strain. There is no published pharmacokinetic study measuring concentrations after dried flower sold under the name Cataract Kush, so the only fair solution is to provide ranges for the route of administration and state clearly where they come from: from studies on the pharmacokinetics of cannabinoids in humans.

After inhalation, the substance bypasses the digestive tract and enters the bloodstream from the lungs, which is why the onset is counted in minutes. The peak of perceived effect occurs later than the peak concentration in the blood, usually 15 to 30 minutes after the session ends, and declines within 2 to 4 hours. Vaporization differs from smoking in the temperature of the process, not in the absorption process.

The oral route proceeds differently, as absorption from the digestive tract is slow and incomplete, and the liver processes part of the dose into a derivative with its own activity. The onset usually occurs after 30 to 90 minutes, the peak after 2 to 4 hours, and the effect can last up to 8 hours. The variability between individuals is significantly greater with this route than with inhalation.

What is known, and what is not known about the effects of Cataract Kush?

Not much. No published clinical study pertains to this strain by name. The evidence that can be cited here relates to myrcene, the component leading its profile, and comes from studies on rodents. The description of the relaxing effect comes from the strain database, not from measurement.

There are three studies on myrcene, and all concern mice. In a 2002 study (PMID: 12587690), intraperitoneal administration at doses of 100-200 mg/kg reduced the animals' locomotor activity and prolonged sleep induced by pentobarbital, and in an elevated plus maze, it produced a rather anxiety-inducing picture. An earlier study from 1990 (PMID: 1983154) described weaker pain responses at 10-40 mg/kg, which were reversed by naloxone. The latest one, from 2024 (PMID: 39728677), used short puffs of vapor, and with this administration, the effect was anxiolytic in females.

In humans, myrcene alone has not been shown to alleviate insomnia at doses typical for inhalation of dried flower. The direction of the effect in rodents depends on the route of administration and sex: intraperitoneal injection in 2002 described a slightly anxiogenic effect, while inhalation in 2024 showed an anxiolytic effect in females. These two results do not negate each other; they simply show that the conclusion depends on conditions that no popular strain database provides.

The rest of what circulates about this strain has a different status. The characterization of the effect as relaxing comes from a strain database maintained by a single source, and it is neither a measurement nor the result of a study with a control group. The same entry provides a set of terpenes for all four medicinal products, so the consistency among them confirms nothing other than that they come from a single note.

What side effects have been reported after using Cataract Kush?

None specifically attributed to this strain by name. Reports are collected for the medicinal product, which here is the dried flower of a specific producer with a specific content, not the cultivar itself. Therefore, no available source provides frequency data for Cataract Kush, and what can be mentioned pertains to the raw material and the method of administration.

Symptoms noted after using dried flower in general are consistent: dry mouth and throat, dizziness, increased heart rate, drowsiness, a drop in blood pressure upon standing, and anxiety at higher doses. None of these items can today be assigned a frequency for the described strain, as data is not collected by cultivar.

The difference between these two paragraphs is not a formality. Four entries for this strain come from three producers, so even if reports were to come in, they would be spread across four separate records with different declared strengths. Assigning a symptom to the strain's name would require batch-level data, which no one publishes.

The conclusion for the reader is simple: the strain description does not replace the leaflet or a conversation with the attending physician. Dried flower is a pharmaceutical raw material dispensed by a doctor's prescription in the Rpw category, and the choice of dosage and method of administration is up to the person issuing the prescription.

At what temperature should you vaporize Cataract Kush?

There is no single correct temperature. Myrcene, which leads the profile of this strain, boils at 166.8 degrees Celsius under atmospheric pressure, but the other components of this set evaporate at different points, spread over a range of more than a hundred degrees. The setting of the vaporizer is not the temperature of the dried flower.

The boiling points in this cluster come from PubChem and not all can be compared with each other. For myrcene, pinene, limonene, linalool, and caryophyllene, the database provides measurements at atmospheric pressure: approximately 167, 156, 178, 196, and 258 degrees Celsius, respectively. For humulene, the only record is 99.5 degrees at a pressure of 3 mmHg, which is a number from a different system that cannot be inserted into the same column..

The practical conclusion is more modest than the tables circulating on forums suggest. Since the components of this profile evaporate over a range of more than a hundred degrees, no single setting will extract them all at once. The lower part of the range releases lighter terpenes, while the upper adds heavier ones and releases cannabinoids more strongly, at the cost of a harsher throat sensation..

The third issue is purely technical. The number on the display describes the heating element or chamber, not the plant material inside, which can be noticeably cooler, depending on the device's construction and how compact the chamber is. A separate text about vaporizer settings breaks down this difference..

Which strains are related to Cataract Kush?

None. Among the strains currently available in Polish pharmacies, this one has no sisters, although its origin has been established. The reason lies with the second parent: OG Kush is a label for the entire family style, not a single plant, so it does not define sibling relationships.

An empty result with a known pedigree is not a gap in the data. A parent listed as a landrace or as a broad family style does not create siblings, as many different plants are hidden under such a label. Two cultivars sharing only such a label are not recognized as siblings because it is unknown whether they have a common ancestor.

In this cluster, OG Kush stands among the parents of two other strains: Galaxy Walker OG and Chemango Kush. None of them is a sister of the described strain for this reason. OG Kush itself appears in pharmacies as a separate entry and has no established origin, which clearly shows how little a common name component carries.

There are four comparisons in which Cataract Kush stands next to another strain in this cluster: with Gorilla Glue, z Beach Crasher, z Galaxy Walker OG oraz z Island Sweet Skunk. These are comparisons of profiles and applications, not declarations of kinship. Those looking for strains with similarly conducted profiles should focus on the leading terpene, not on drzewo genealogiczne.

Frequently Asked Questions about Cataract Kush

Is Cataract Kush an indica strain?

Yes. Both sources describing this strain consistently classify it as indica, and the consistency pertains to the classification itself, not the profile composition.

How many producers supply Cataract Kush to Polish pharmacies?

Three: S-LAB, Synoptis Pharma, and Tilray. Together, they account for four registered items, as Tilray offers two versions with different declared strengths.

Does the terpene profile of Cataract Kush confirm more than one source?

No. The composition is described by one source, so there is nothing to compare it to or confirm it with, and it should be read as such.

Does Cataract Kush have a documented lineage?

Yes. The parents are listed as LA Confidential and OG Kush, and the crossbreed is attributed to the breeding of DNA Genetics. This is a breeder's declaration, not a result of genetic testing.

Are there clinical studies on the Cataract Kush strain?

No. There is no published clinical study specifically on this strain, and available work on myrcene has been conducted on rodents.

Can you buy Cataract Kush dried flower without a prescription?

No. Hemp flower falls under the Rpw category, meaning it is issued only by a doctor's prescription, on a prescription written by an authorized physician.

The material is for informational purposes only and does not replace medical advice or the leaflet included with the packaging. Editorial text from the editorial team of ubucha.pl.